Cargando…

Gene-expression analysis of clozapine treatment in whole blood of patients with psychosis

OBJECTIVES: Clozapine is an atypical antipsychotic primarily prescribed for treatment-resistant schizophrenia. We tested the specific effect of clozapine versus other drug treatments on whole-blood gene expression in a sample of patients with psychosis from the UK. METHODS: A total of 186 baseline w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harrison, Rebecca N.S., Murray, Robin M., Lee, Sang Hyuck, Paya Cano, Jose, Dempster, David, Curtis, Charles J., Dima, Danai, Gaughran, Fiona, Breen, Gerome, de Jong, Simone
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010277/ https://www.ncbi.nlm.nih.gov/pubmed/27315048 http://dx.doi.org/10.1097/YPG.0000000000000140

Ejemplares similares

Development of multivariable models to predict change in Body Mass Index within a clinical trial population of psychotic individuals
por: Harrison, Rebecca N. S., et al.
Publicado: (2017)

The polygenic risk for bipolar disorder influences brain regional function relating to visual and default state processing of emotional information
por: Dima, Danai, et al.
Publicado: (2016)

Clozapine and COVID-19
por: Silva, Edward, et al.
Publicado: (2020)

Telomere length as a predictor of emotional processing in the brain
por: Powell, Timothy R., et al.
Publicado: (2018)

Clozapine for mitochondrial psychosis()
por: Finsterer, Josef, et al.
Publicado: (2017)

Telomere Length and Bipolar Disorder
por: Powell, Timothy R, et al.
Publicado: (2018)

Telomere Length and Bipolar Disorder
por: Powell, Timothy R, et al.
Publicado: (2018)

Clozapine Efficacy in a Case of Severe Treatment-Resistant Postpartum Psychosis
por: Teodorescu, Andreea, et al.
Publicado: (2021)

Authors' reply — Clozapine for mitochondrial psychosis
por: Demily, Caroline, et al.
Publicado: (2017)

Loxapine in patient with clozapine-resistant psychosis
por: Erley, Jennifer, et al.
Publicado: (2021)

Management of clozapine treatment during the COVID-19 pandemic
por: Gee, Siobhan, et al.
Publicado: (2020)

Treating Methamphetamine-Induced Resistant Psychosis with Clozapine
por: Seddigh, Ruohollah, et al.
Publicado: (2014)

Clozapine in First Episode Psychosis: The best is delayed
por: Rodrigues, J. B., et al.
Publicado: (2023)

S24. IS IT FEASIBLE TO PREDICT LONG-TERM METABOLIC OUTCOMES IN PSYCHOSIS USING BIOLOGICAL PROFILING AT BASELINE?
por: Iyegbe, Conrad, et al.
Publicado: (2018)

Differential gene expression analysis in blood of first episode psychosis patients
por: Leirer, Daniel J., et al.
Publicado: (2019)

Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response
por: Aboueid, Lila, et al.
Publicado: (2016)

Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort
por: Santoro, Marcos Leite, et al.
Publicado: (2018)

Treatment resistant psychosis in children and adolescents and clozapine: Nuances
por: Pattnaik, Jigyansa Ipsita, et al.
Publicado: (2023)

Clozapine prescribing during follow-up of a first-episode psychosis cohort
por: Rowntree, R., et al.
Publicado: (2021)

Complement system biomarkers in first episode psychosis
por: Kopczynska, Maja, et al.
Publicado: (2019)

Psychosis or Obsessions? Clozapine Associated with Worsening Obsessive-Compulsive Symptoms
por: Leung, Jonathan G., et al.
Publicado: (2016)

Associations between polygenic loading, psychosis liability, and clozapine use
por: Luykx, J.
Publicado: (2023)

Clozapine in first episode psychosis – the experience of a Portuguese center
por: Soares Da Costa, I., et al.
Publicado: (2023)

T183. LOW LEVELS OF VITAMIN D ARE ASSOCIATED WITH REDUCED CORTICAL THICKNESS AND SURFACE AREA IN FRONTAL, TEMPORAL AND OCCIPITAL REGIONS IN FIRST-EPISODE PSYCHOSIS PATIENTS
por: Ciufolini, Simone, et al.
Publicado: (2020)

Physical Health Problems in Psychosis: Is It Time to Consider the Views of Family Carers?
por: Onwumere, Juliana, et al.
Publicado: (2018)

Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?
por: Hindocha, Chandni, et al.
Publicado: (2020)

Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations
por: Krivoy, Amir, et al.
Publicado: (2021)

Dietary intake, physical activity and sedentary behaviour patterns in a sample with established psychosis and associations with mental health symptomatology
por: Martland, Rebecca, et al.
Publicado: (2023)

Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis
por: Shirazi, Ayala, et al.
Publicado: (2016)

Integrative Genomic–Epigenomic Analysis of Clozapine-Treated Patients with Refractory Psychosis
por: Mayén-Lobo, Yerye Gibrán, et al.
Publicado: (2021)

Evaluation of a Physical health plan for people with psychosis: a protocol for a quality improvement study
por: Williams, Julie, et al.
Publicado: (2019)

Does environmental confounding mask pleiotropic effects of a multiple sclerosis susceptibility variant on vitamin D in psychosis?
por: Iyegbe, Conrad O, et al.
Publicado: (2015)

Cognitive Behavioral Therapy Normalizes Functional Connectivity for Social Threat in Psychosis
por: Mason, Liam, et al.
Publicado: (2016)

DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia
por: Hannon, Eilis, et al.
Publicado: (2021)

Successful rechallenge with paliperidone after clozapine treatment for a patient with dopamine supersensitivity psychosis
por: Kobayashi, Remiko, et al.
Publicado: (2020)

Audit on clozapine dose and plasma level correlation for patients with chronic treatment-resistant psychosis
por: Macnamara, Olivia, et al.
Publicado: (2021)

Clozapine-related immunodeficiency: Implications for Parkinson's disease psychosis in the context of the COVID-19 pandemic
por: Aubignat, M.
Publicado: (2021)

O5.2. PREDICTORS OF CARDIOMETABOLIC RISK IN THE YEAR AFTER ONSET OF PSYCHOSIS: A PROSPECTIVE COHORT STUDY
por: Gaughran, Fiona, et al.
Publicado: (2018)

Clozapine point of care testing in acute psychiatry: A precision approach to treatment resistant psychosis
por: Boland, X., et al.
Publicado: (2021)

Clozapine for treatment resistance in early psychosis: a survey of UK clinicians’ training, knowledge and confidence
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2k22vqp9m96usfjc5nfbnugnk3